aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.824
-0.004 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
0.820
-0.004 (-0.47%)
After-hours: Dec 5, 2025, 7:58 PM EST
aTyr Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 81 | 304 | 83 | 64 | 208 | 40 | |
| Market Cap Growth | -68.05% | 268.02% | 29.97% | -69.40% | 425.30% | 143.62% | |
| Enterprise Value | 3 | 251 | -5 | -5 | 93 | 9 | |
| Last Close Price | 0.82 | 3.62 | 1.41 | 2.19 | 7.47 | 3.88 | |
| PS Ratio | 424.90 | 1293.07 | 233.91 | 6.12 | - | 3.78 | |
| PB Ratio | 1.01 | 4.35 | 0.91 | 0.89 | 1.90 | 1.25 | |
| P/TBV Ratio | 1.01 | 4.34 | 0.91 | 0.89 | 1.90 | 1.25 | |
| EV/Sales Ratio | 15.20 | 1069.23 | - | - | - | 0.83 | |
| Debt / Equity Ratio | 0.15 | 0.19 | 0.17 | 0.16 | 0.01 | 0.07 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.10 | - | 0.28 | |
| Quick Ratio | 5.82 | 4.93 | 6.13 | 5.62 | 18.02 | 5.41 | |
| Current Ratio | 5.93 | 5.48 | 6.27 | 5.83 | 18.89 | 6.06 | |
| Return on Equity (ROE) | -103.49% | -79.88% | -62.31% | -50.27% | -48.04% | -61.82% | |
| Return on Assets (ROA) | -49.59% | -39.03% | -31.72% | -27.45% | -27.56% | -26.55% | |
| Return on Capital (ROIC) | -57.46% | -44.99% | -36.44% | -30.00% | -29.48% | -29.92% | |
| Return on Capital Employed (ROCE) | -86.50% | -83.00% | -52.70% | -56.60% | -31.10% | -48.40% | |
| Earnings Yield | -93.05% | -21.07% | -61.03% | -71.36% | -16.27% | -41.05% | |
| FCF Yield | -78.03% | -22.77% | -45.34% | -68.51% | -16.02% | -39.23% | |
| Buyback Yield / Dilution | -30.37% | -38.53% | -88.63% | -48.94% | -108.30% | -172.99% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.